Toru Watanabe

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer et al. · Annals of Oncology · 2017 · 1.2K citations · Full text

Comparison of Fulvestrant Versus Tamoxifen for the Treatment of Advanced Breast Cancer in Postmenopausal Women Previously Untreated With Endocrine Therapy: A Multinational, Double-Blind, Randomized Trial

Anthony Howell, J.F.R. Robertson, P. Abram et al. · Journal of Clinical Oncology · 2004 · 424 citations · Full text

Development of a Dose-Response Model for SARS Coronavirus

Toru Watanabe, Timothy A. Bartrand, Mark H. Weir et al. · Risk Analysis · 2010 · 409 citations · Full text

Infectious Disease Modelling, Virus Epidemiology, Global Health +12

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi et al. · Supportive Care in Cancer · 2009 · 197 citations

Oncology, Taxane Chemotherapy, Phase Iii +7

Toxicity Grading Criteria of the Japan Clinical Oncology Group

Kensei Tobinai, Akio Kohno, Yasuhiro Shimada et al. · Japanese Journal of Clinical Oncology · 1993 · 173 citations

Surgical Oncology, Cancer Management, Pathology +17